Regional Biocontainment Laboratory (RBL) for Region V

V 区区域生物防护实验室 (RBL)

• 批准号: 6712171
• 负责人: JOHN Keith MOFFAT
• 金额: $ 1737.48万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6712171
• 关键词: Regional; Biocontainment; Laboratory; RBL; Region

DESCRIPTION (provided by applicant): The Ricketts (Regional Biocontainment) Laboratory would be constructed in a secure area leased from the Department of Energy at Argonne National Laboratory near Chicago, Illinois. It would serve the research, translational research, research training, service, and emergency response functions of the Midwest RCE (Regional Center of Excellence). The Midwestern RCE includes Region V scientists from Argonne National Laboratory, Battelle Memorial Institute, Illinois Institute of Technology, Mayo Clinic, Medical College of Wisconsin, Michigan State University, Northwestern University, Notre Dame University, Purdue University, University of Chicago, University of Illinois at Urbana-Champaign, University of Michigan, and University of Wisconsin. Intellectual contributions from over 100 scientists produced twenty-five inter-disciplinary, inter-institutional research programs selected by competitive peer review. The programs focus on studying CDC Category A Select Agents to develop new therapeutics, vaccines and diagnostic devices. Review mechanisms will provide access for NIAID supported non-RCE scientists, including proprietary research. An emergency response plan provides training and, when necessary complete commitment to emergency responders. The Ricketts Laboratory would have 54,100 square feet (27,500 net square feet (NSF)), with 8,900 NSF of BSL-2/BSL-3 molecular laboratory space and 13,300 NSF of BSL-2/BSL-3 animal research laboratories. It would have the capacity for simultaneous study of four or more different Select Agent Category A pathogens, by the research groups of five principal investigators and thirty-five staff scientists, with a total holding capacity for about 30,000 mice or other experimental animals.

描述（由申请人提供）：将在伊利诺伊州芝加哥附近的Argonne National Laboratory的能源部租用的安全区域中建造Ricketts（区域生物疗法）实验室。它将为中西部RCE（区域卓越中心）的研究，翻译研究，研究培训，服务和应急功能提供服务。中西部RCE包括来自阿贡国家实验室的地区V科学家，巴特尔纪念研究所，伊利诺伊理工学院，梅奥诊所，威斯康星州医学院，密歇根州立大学，西北大学，巴黎圣母院，普渡大学，普渡大学，芝加哥大学，芝加哥大学，伊利诺伊州大学，伊利诺伊州大学 - 坎帕尼大学，密歇根大学，伊利诺伊州培训，密歇根州和科学大学。来自100多名科学家的智力贡献产生了二十五个由竞争同行评审选择的跨学科，机构间研究计划。该计划着重于研究CDC类别的特定代理，以开发新的治疗剂，疫苗和诊断设备。审查机制将为包括专有研究在内的NIAID支持的非RCE科学家提供访问权限。紧急响应计划提供培训，并在必要时对紧急响应者进行全面承诺。立克实验室将拥有54,100平方英尺（27,500平方英尺（NSF）），其中8,900 NSF的BSL-2/BSL-3分子实验室空间和13,300 NSF的BSL-2/BSL-2/BSL-3动物研究实验室。这将具有同时研究四个或更多不同的选择剂类别A病原体的能力，由五名主要研究人员和35名员工科学家组成的研究小组，总计约30,000只小鼠或其他实验动物。